PATH
Menu

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Corporate author(s): PATH; Instituto de Investigación Nutricional; Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones

Publication date: December 2010

Available materials

English

Spanish

HPV Vaccination in Latin America (full document) [Spanish]

608 KB PDF

Also known as: Vacunación Contra el Virus del Papiloma Humano en América Latina

HPV Vaccination in Latin America (executive summary) [Spanish]

251 KB PDF

Also known as: Vacunación Contra el Virus del Papiloma Humano en América Latina

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

This publication is part of the series HPV vaccination project lessons learned reports

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA